News
Video
Podcasts
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

February 2002

Evaluation of Agreements Between Managed Care Organizations and Providers of Community-Based Mental Illness and Addiction Disorder Treatments

BySara Rosenbaum, JD,D. Richard Mauery, MPH,Joel Teitelbaum, LLM,Rita Vandivort-Warren, ACSW

February 1st 2002

"Trial" Prescriptions to Reduce Drug Wastage: Results From Canadian Programs and a Community Demonstration Project

ByJ. Michael Paterson MSc,Geoffrey M. Anderson, MD, PhD

February 1st 2002

Application of Pharmacoeconomics to Formulary Decision Making in Managed Care Organizations

ByDong-Churl Suh, PhD, MBA,Ijeoma R. N. Okpara, PharmD,Wendy B. Agnese, PharmD,Michael Toscani, PharmD

February 1st 2002

Comparison of Two Systems for Clinical Practice Profiling in Diabetic Care: Medical Records Versus Claims and Administrative Data

ByJ. Ross Maclean, MD,Donna M. Fick, RN, PhD,Wayne K. Hoffman, MD,Coleman T. King, MD,Eric R. Lough, MD,Jennifer L. Waller, PhD

February 1st 2002

A Comparison of Ambulatory Services for Patients with Managed Care and Fee-for-Service Insurance

ByGeorge E. Kikano, MD,Clint W. Snyder, PhD,Edward J. Callahan, PhD,Meredith A. Goodwin, MS,Kurt C. Stange, MD, PhD

February 1st 2002

A New Method for Determining Patient Payments for Outpatient Drugs

ByDana P. Goldman, PhD,A. Mark Fendrick, MD,Dean G. Smith, PhD,Michael E. Chernew, PhD

February 1st 2002

Expanded Use of Nurse Practitioners

ByWilbur T. Hill, DO

February 1st 2002

Trending on AJMC

Tirzepatide Plus Hormone Therapy Boosts Weight Loss in Menopause: Regina Castaneda, MD

FDA Approves Elinzanetant, a Hormone-Free Option for Hot Flashes in Menopause

GLP-1 Receptor Agonists May Improve Rheumatoid Arthritis Symptoms

Elinzanetant Shows Strong 52-Week Safety for Vasomotor Symptoms: James Simon, MD

Serum Spectroscopy Reveals Prognostic Risk Factors in CLL

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

© 2025 MJH Life Sciences^®

All rights reserved.